新型冠状病毒病19诱导的急性呼吸窘迫综合征循环氧化还原平衡的改变
本研究比较了COVID-19阳性ARDS患者(N=40)与COVID-19阴性ARDS患者(N=42),检测血清和红细胞的氧化还原平衡标志物,并与炎症和凝血标志物进行关联分析。结果显示两组血清氧化损伤标志物无差异,但COVID-19组血清总抗氧化状态和铜蓝蛋白水平降低;红细胞氧化还原平衡改变表现为脂褐素和丙二醛浓度升高、谷胱甘肽S-转移酶和谷胱甘肽还原酶活性降低。在COVID-19 ARDS患者中,这些标志物与呼吸疾病严重程度指标(Horowitz指数和肺泡-动脉氧梯度)、炎症指标(白细胞介素-6和白细胞介素-10)以及高凝状态指标(D-二聚体)相关。结论认为COVID-19所致ARDS存在氧化还原平衡损害,尤其在红细胞中,且这种改变与严重COVID-19特征性的促炎和促凝状态相关。
要点
- COVID-19 ARDS患者较非COVID-19 ARDS患者血清总抗氧化状态和铜蓝蛋白水平降低,提示抗氧化能力受损。
- COVID-19 ARDS患者红细胞脂褐素和丙二醛浓度升高,谷胱甘肽S-转移酶和谷胱甘肽还原酶活性降低,提示红细胞氧化还原平衡改变。
- 在COVID-19 ARDS患者中,上述氧化还原标志物与呼吸疾病严重程度指标(Horowitz指数和肺泡-动脉氧梯度)、炎症指标(白细胞介素-6和白细胞介素-10)及高凝状态指标(D-二聚体)相关。
- 两组血清氧化损伤标志物未见差异,提示COVID-19 ARDS的氧化还原改变可能更突出于红细胞层面。
适用人群与场景
- 纳入COVID-19阳性ARDS患者40例(COVID-19组)与COVID-19阴性ARDS患者42例(No COVID-19组)进行比较。
研究设计与关键结果
- 研究类型为比较性研究,纳入COVID-19阳性ARDS患者40例与COVID-19阴性ARDS患者42例,检测血清和红细胞的氧化还原平衡标志物,并与炎症和凝血标志物进行关联分析。
- 两组血清氧化损伤标志物无差异;COVID-19组较No COVID-19组血清总抗氧化状态和铜蓝蛋白水平降低。
- COVID-19组较No COVID-19组红细胞脂褐素和丙二醛浓度升高,谷胱甘肽S-转移酶和谷胱甘肽还原酶活性降低。
- 在COVID-19 ARDS患者中,这些氧化还原标志物与呼吸疾病严重程度指标(Horowitz指数和肺泡-动脉氧梯度)、炎症指标(白细胞介素-6和白细胞介素-10)及高凝状态指标(D-二聚体)相关。
证据类型、等级与局限
- 证据类型:比较性研究(COVID-19阳性ARDS患者40例 vs COVID-19阴性ARDS患者42例);局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Mechanisms underpinning ARDS induced by COVID-19 are mostly immune-mediated, but need to be completely clarified. This study aimed to investigate redox balance in COVID-19 patients with ARDS, trying to recognize possible differences from typical ARDS related to the pathophysiology of severe disease.
METHODS: Patients affected by ARDS and positive for the SARS-CoV-2 virus (N = 40, COVID-19) were compared to ARDS patients negative to the molecular test (N = 42, No COVID-19). Circulating markers of redox balance were measured in serum and erythrocytes, and related to markers of inflammation and coagulability.
RESULTS: No differences in serum markers of oxidative damage were found between both groups, but a reduction in total antioxidant status and serum ceruloplasmin level was observed in COVID-19 rather than No COVID-19 patients. Redox balance alterations were described in erythrocytes from COVID-19 with respect to No COVID-19 group, characterized by increased lipofuscin and malondialdehyde concentration, and reduced glutathione S-transferase and glutathione reductase activity. These markers were associated with circulating indexes of respiratory disease severity (Horowitz index and alveolar-to-arterial oxygen gradient), inflammation (interleukin-6 and interleukin-10), and hypercoagulability (D-dimer) in COVID-19 patients with ARDS.
CONCLUSIONS: ARDS caused by COVID-19 is sustained by impairment of redox balance, particularly in erythrocytes. This alteration is associated with the pro-inflammatory and pro-coagulant status which characterizes severe COVID-19.
参考来源
- Bellanti F, Kasperczyk S, Kasperczyk A, et al. Alteration of circulating redox balance in coronavirus disease-19-induced acute respiratory distress syndrome. J Intensive Care. 2023. PMID: 37408073. doi:10.1186/s40560-023-00679-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。